Mortality Trends in Atrial Fibrillation With Cardiomyopathy Among Patients Aged 25 and Older in the United States
Open Access
- 14 October 2025
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (12) , 1434-1443
Abstract
Background: Atrial fibrillation (AF) is a prevalent arrhythmia that frequently coexists with cardiomyopathy, leading to deteriorated cardiovascular outcomes. Analyzing the trends associated with these conditions is essential for improving prevention strategies and management practices. Methods: CDC WONDER (1999–2023) data were analyzed to assess AF with cardiomyopathy‐related mortality in patients aged ≥ 25. Using Joinpoint regression analysis, we calculated age‐adjusted mortality rates (AAMRs) per 100,000 patients and average annual percentage changes (AAPCs) to analyze mortality trends. Results: AF with cardiomyopathy is responsible for 126,377 deaths among adults aged 25 and older. Alarmingly, AAMRs have surged from 1.8 per 100,000 in 1999 to 3.0 in 2023 (AAPC: 2.11, p < 0.001). The upward trend remains pronounced, particularly between 2016 and 2021, with an annual percentage change of 6.17 ( p = 0.02). Disparities in mortality rates are striking. Men face a higher AAMR than women (3.1 vs. 1.5), and Black individuals bear the heaviest burden at 2.4, closely followed by Whites at 2.3. Regionally, Vermont stands out with the highest AAMR at 3.6, while New York reports the lowest at 1.3. Both rural and urban areas maintain equal AAMRs of 2.1, yet the increase in rural regions is particularly concerning, reflecting an AAPC of 2.44 compared to 1.78 in urban settings. Conclusion: The rising mortality rates from AF with cardiomyopathy in patients, particularly among men, Black individuals, and rural residents, demand urgent action. These concerning trends underscore a public health crisis that must be addressed.Keywords
This publication has 28 references indexed in Scilit:
- The Anterior Mitral Valve Leaflet Prolapse as a Key to Diagnosis of ALCAPA SyndromeJACC, 2024
- Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysisHeart Rhythm, 2024
- Tachycardia and Atrial Fibrillation-Related CardiomyopathiesJACC: Heart Failure, 2024
- Sex Differences in Heart FailureJournal of Cardiac Failure, 2022
- Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJACC, 2020
- Mechanisms and Clinical Significance of Arrhythmia-Induced CardiomyopathyCanadian Journal of Cardiology, 2018
- Catheter Ablation for Atrial Fibrillation with Heart FailureNew England Journal of Medicine, 2018
- Urban-rural differences in mortality for atrial fibrillation hospitalizations in the United StatesHeart Rhythm, 2018
- Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation RegistryAmerican Heart Journal, 2016
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEuropean Heart Journal, 2006